{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":11,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":11,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"7bfd0db550be","filters":{"venue":"Kidney Cancer"}},"results":[{"id":"W2605821659","doi":"10.3233/kca-160002","title":"Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)","year":2017,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; Sunnybrook Health Science Centre; University of Calgary","funders":"Foundation Medicine; Astellas Pharma; Eisai; National Comprehensive Cancer Network; GlaxoSmithKline; Exelixis; Genentech; AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Renal cell carcinoma; Medicine; Chromophobe cell; Oncology; Targeted therapy; Cancer; Internal medicine; Clear cell","authors":[{"name":"Steven Yip","is_ca":true},{"name":"José Manuel Ruiz Morales","is_ca":false},{"name":"Frede Donskov","is_ca":false},{"name":"Anna Paola Fraccon","is_ca":false},{"name":"Umberto Basso","is_ca":false},{"name":"Brian I. Rini","is_ca":false},{"name":"Jae‐Lyun Lee","is_ca":false},{"name":"Georg A. Bjarnason","is_ca":true},{"name":"Hao‐Wen Sim","is_ca":true},{"name":"Benoit Beuselinck","is_ca":false},{"name":"Ravindran Kanesvaran","is_ca":false},{"name":"James Brugarolas","is_ca":false},{"name":"K. Koutsoukos","is_ca":false},{"name":"Simon Fu","is_ca":false},{"name":"Takeshi Yuasa","is_ca":false},{"name":"Ian D. Davis","is_ca":false},{"name":"Ajjai Alva","is_ca":false},{"name":"Christian Kollmannsberger","is_ca":true},{"name":"Toni K. Choueiri","is_ca":false},{"name":"Daniel Y.C. Heng","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05602898733680911,"gpt":0.3205884367928813,"spread":0.2645594494560722,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008139898,0.0004860331,0.0008183024,0.0001309246,0.0002650486,0.0001135419,0.001188132,0.00006842699,0.00127901],"category_scores_gemma":[0.0004481377,0.000259921,0.0003151698,0.0001818362,0.0003791791,0.0002691215,0.0001836489,0.0005601492,0.00002590028],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003870303,"about_ca_system_score_gemma":0.001530229,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04967901,"about_ca_topic_score_gemma":0.002946386,"domain_scores_codex":[0.9963819,0.0003312101,0.0009403678,0.0007143106,0.001128545,0.0005036599],"domain_scores_gemma":[0.995979,0.0006659077,0.0009195032,0.001898162,0.0002592783,0.0002781821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007703631,0.002329659,0.4448826,0.0002858321,0.002783217,0.001715694,0.01131916,0.0002687357,0.3501428,0.00006963118,0.1745229,0.003976133],"study_design_scores_gemma":[0.01840645,0.0003164218,0.6733741,0.0002891105,0.0009298189,0.00001819459,0.0005448525,0.0004519584,0.288509,0.0000788471,0.01670488,0.0003763422],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9611738,0.006239336,0.00001898916,0.01965885,0.0008611743,0.001350325,0.007412632,0.00002078491,0.003264087],"genre_scores_gemma":[0.9893741,0.002062699,0.0008820061,0.004722827,0.0003240338,0.0004647929,0.0008150343,0.00005654267,0.001297955],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2284915,"threshold_uncertainty_score":0.9999853,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2787239315","doi":"10.3233/kca-170020","title":"Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)","year":2018,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Axitinib; Sorafenib; Renal cell carcinoma; Internal medicine; Oncology; Everolimus; Temsirolimus; Proportional hazards model; Targeted therapy; Retrospective cohort study; Urology; Surgery; Cancer; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors","authors":[{"name":"Igor Stukalin","is_ca":false},{"name":"J. Connor Wells","is_ca":true},{"name":"Anna Paola Fraccon","is_ca":false},{"name":"Felice Pasini","is_ca":false},{"name":"Camillo Porta","is_ca":false},{"name":"Aly‐Khan A. Lalani","is_ca":false},{"name":"Sandy Srinivas","is_ca":false},{"name":"I. Alex Bowman","is_ca":false},{"name":"James Brugarolas","is_ca":false},{"name":"Jae‐Lyun Lee","is_ca":false},{"name":"Frede Donskov","is_ca":false},{"name":"Benoit Beuselinck","is_ca":false},{"name":"Aristotelis Bamias","is_ca":false},{"name":"Brian I. Rini","is_ca":false},{"name":"Hao‐Wen Sim","is_ca":true},{"name":"Neeraj Agarwal","is_ca":false},{"name":"Sun Young Rha","is_ca":false},{"name":"Ravindran Kanesvaran","is_ca":false},{"name":"Toni K. Choueiri","is_ca":false},{"name":"Daniel Y.C. Heng","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05521137413412077,"gpt":0.3092914079217557,"spread":0.2540800337876349,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038722,0.0002934611,0.0003665196,0.0001137309,0.00008286448,0.00004299047,0.0003407805,0.00006220709,0.002249164],"category_scores_gemma":[0.00029687,0.0001876512,0.0001269467,0.0002476935,0.0002176378,0.0001193801,0.0001099148,0.0003056993,0.0001645147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004031881,"about_ca_system_score_gemma":0.0008783158,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009027652,"about_ca_topic_score_gemma":0.00128058,"domain_scores_codex":[0.9977309,0.0001267196,0.000561236,0.0006003182,0.0006023473,0.0003784799],"domain_scores_gemma":[0.9981216,0.0002827678,0.0002132977,0.0008180108,0.0002260199,0.0003383654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01916683,0.001580526,0.1438784,0.00007539505,0.001067413,0.001970812,0.006389466,0.00005448635,0.2261468,0.0000965064,0.5788256,0.02074774],"study_design_scores_gemma":[0.03582608,0.00147738,0.1902698,0.0005127738,0.0004656911,0.00007377914,0.0004868008,0.002987468,0.5107567,0.0001997877,0.25634,0.0006037156],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.966716,0.001785399,0.00008486665,0.0198133,0.001046663,0.0007641985,0.00268761,0.00004012491,0.007061837],"genre_scores_gemma":[0.9836946,0.000582165,0.001540497,0.009086844,0.001387578,0.0001372592,0.001106451,0.0000445538,0.00242006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3224855,"threshold_uncertainty_score":0.9986629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2741346996","doi":"10.3233/kca-170010","title":"Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC—A Possible Path Forward","year":2017,"lang":"en","type":"review","venue":"Kidney Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University","funders":"ECOG-ACRIN Cancer Research Group; European Association of Urology; American College of Radiology Imaging Network; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Perioperative; Nephrectomy; Oncology; Adjuvant therapy; Internal medicine; Clinical trial; Surgery; Immunotherapy; Chemotherapy; Kidney; Cancer","authors":[{"name":"Lauren C. Harshman","is_ca":false},{"name":"Charles G. Drake","is_ca":false},{"name":"Naomi B. Haas","is_ca":false},{"name":"Judith Manola","is_ca":false},{"name":"Mäneka Puligandla","is_ca":false},{"name":"Sabina Signoretti","is_ca":false},{"name":"David Cella","is_ca":false},{"name":"Rajan T. Gupta","is_ca":false},{"name":"Rupal S. Bhatt","is_ca":false},{"name":"Eliezer M. Van Allen","is_ca":false},{"name":"Primo N. Lara","is_ca":false},{"name":"Toni K. Choueiri","is_ca":false},{"name":"Anil Kapoor","is_ca":true},{"name":"D.Y.C. Heng","is_ca":false},{"name":"Michael A.S. Jewett","is_ca":true},{"name":"Daniel J. George","is_ca":false},{"name":"M. Dror Michaelson","is_ca":false},{"name":"Michael A. Carducci","is_ca":false},{"name":"David F. McDermott","is_ca":false},{"name":"Mohamad E. Allaf","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07852159444762236,"gpt":0.3996867316737452,"spread":0.3211651372261229,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002867637,0.0005897387,0.001985538,0.0001602016,0.0002619365,0.0001033226,0.0002890316,0.0001789387,0.000632521],"category_scores_gemma":[0.00003393125,0.0003039124,0.000849223,0.0002394882,0.000183043,0.0001143385,0.00001815578,0.0003620767,0.00003557982],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001445112,"about_ca_system_score_gemma":0.003959899,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002469301,"about_ca_topic_score_gemma":0.0006304958,"domain_scores_codex":[0.9980246,0.0001016308,0.0006436967,0.0004878757,0.0002661791,0.0004760532],"domain_scores_gemma":[0.9986206,0.00007660027,0.0003086671,0.0007369087,0.00003121107,0.0002259673],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002083828,0.00009760275,0.00002469539,0.004299981,0.001010967,0.00008533832,0.001688254,3.124833e-7,0.00000559147,0.00001077415,0.001907331,0.9906608],"study_design_scores_gemma":[0.002849961,0.0003768769,0.00004003226,0.02271228,0.001634233,0.00008254757,0.00007549997,0.000008634015,0.00001957021,0.000006498469,0.9718605,0.0003333533],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002631093,0.9901512,0.00001674355,0.001542373,0.000581217,0.003405407,0.0004767463,0.00002033234,0.003779662],"genre_scores_gemma":[0.00007323656,0.9890068,0.00004673663,0.0009113607,0.0003136943,0.00263435,0.0001438177,0.00007782469,0.006792133],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9903274,"threshold_uncertainty_score":0.9999413,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2997361961","doi":"10.3233/kca-190077","title":"Individualization of Dose and Schedule Based On Toxicity for Oral VEGF Drugs in Kidney Cancer","year":2019,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Dosing; Medicine; Toxicity; Vascular endothelial growth factor; Cancer; Drug; Tyrosine-kinase inhibitor; Adjuvant; Oncology; VEGF receptors; Pharmacology; Internal medicine","authors":[{"name":"Ambika Parmar","is_ca":true},{"name":"Georg A. Bjarnason","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0229485505792703,"gpt":0.3077115109704465,"spread":0.2847629603911762,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001663322,0.0001655165,0.0003546718,0.0001605561,0.00002204567,0.000009339079,0.00005444589,0.0001005389,0.0007680557],"category_scores_gemma":[0.0001292727,0.0001382312,0.00006413238,0.000213062,0.00004210291,0.00006434341,0.00002059697,0.00009518905,0.000006059629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003737146,"about_ca_system_score_gemma":0.0009133553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009301958,"about_ca_topic_score_gemma":0.00008222339,"domain_scores_codex":[0.9989151,0.00003634147,0.0002356766,0.0003144947,0.0002727167,0.0002256862],"domain_scores_gemma":[0.9991989,0.00004874368,0.0001107424,0.000238027,0.00009523347,0.0003083463],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001899063,0.0004950278,0.9499784,0.001709897,0.0001282716,0.000005099275,0.001090071,0.0003672101,0.02862253,0.0001936663,0.007676043,0.00783477],"study_design_scores_gemma":[0.03093656,0.001908183,0.6586628,0.003857602,0.0004293854,0.000002616529,0.0001579899,0.01512761,0.2641253,0.0001440715,0.02411463,0.0005333173],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935111,0.0004894471,0.00002676606,0.002641993,0.0002640242,0.001205896,0.0003502695,0.00001918995,0.001491267],"genre_scores_gemma":[0.9934726,0.0001044039,0.0005989817,0.004533871,0.00007822544,0.0002971302,0.0001334393,0.00003023525,0.0007511594],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2913156,"threshold_uncertainty_score":0.8409671,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3135371333","doi":"10.3233/kca-210110","title":"Real-Word Experience of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis)","year":2021,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"CancerCare Manitoba; St Joseph's Health Centre; University of Ottawa; Sunnybrook Health Science Centre; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Toronto; Western University; Princess Margaret Cancer Centre; University of Calgary; Centre hospitalier universitaire de Québec; London Health Sciences Centre; Alberta Health Services; McMaster University; University of Manitoba; Juravinski Cancer Centre; Université Laval; University of Alberta","funders":"Genentech; Ipsen; Astellas Pharma; Eisai; Karyopharm Therapeutics; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Exelixis; GlaxoSmithKline","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Kidney cancer; Internal medicine; Cancer; Oncology; Tyrosine-kinase inhibitor; Population; Urology; Surgery; Gastroenterology","authors":[{"name":"Han‐Bo Zhang","is_ca":true},{"name":"Naveen S. Basappa","is_ca":true},{"name":"Sunita Ghosh","is_ca":true},{"name":"Isaiah Joy","is_ca":true},{"name":"Aly‐Khan A. Lalani","is_ca":true},{"name":"Aaron R. Hansen","is_ca":true},{"name":"Daniel Y.C. Heng","is_ca":true},{"name":"Vincent Castonguay","is_ca":true},{"name":"Christian Kollmannsberger","is_ca":false},{"name":"Eric Winquist","is_ca":true},{"name":"Lori Wood","is_ca":true},{"name":"Georg A. Bjarnason","is_ca":true},{"name":"Rodney H. Breau","is_ca":true},{"name":"Anil Kapoor","is_ca":true},{"name":"Jeffrey Graham","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02726936905650948,"gpt":0.2753342238878853,"spread":0.2480648548313758,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002792727,0.0003132404,0.0005945812,0.0001868686,0.0001440827,0.00005686002,0.0002359829,0.0001242993,0.0004576178],"category_scores_gemma":[0.0004025935,0.0002331971,0.0001449814,0.0007519791,0.0001193016,0.0002617369,0.00006387375,0.0003092846,0.00003067341],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001931526,"about_ca_system_score_gemma":0.01012211,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8798737,"about_ca_topic_score_gemma":0.4029926,"domain_scores_codex":[0.9972295,0.0001790247,0.0009401884,0.0004425809,0.0006594352,0.0005493421],"domain_scores_gemma":[0.9972461,0.0001255184,0.0003818143,0.0008344064,0.000416204,0.0009958871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004071716,0.0003857704,0.621343,0.00273692,0.000819444,0.003095264,0.1117646,0.000995275,0.04911506,0.0004606628,0.193248,0.01196435],"study_design_scores_gemma":[0.01282351,0.0001789033,0.5511186,0.003097568,0.0007270616,0.00007172352,0.008864079,0.001501897,0.3296446,0.00001167036,0.09131582,0.0006446504],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9718836,0.001351613,0.00000611911,0.004795017,0.0007326995,0.0008105768,0.003915533,0.00003169226,0.01647314],"genre_scores_gemma":[0.9947554,0.0003810527,0.0004226752,0.002285492,0.0001914703,0.0003684856,0.0007382254,0.00003101129,0.0008261832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4768811,"threshold_uncertainty_score":0.9954896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4396814048","doi":"10.3233/kca-230025","title":"Patient Selection for Active Surveillance for Small Renal Masses: A Systematic Review of the Literature","year":2024,"lang":"en","type":"review","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Concordance; Systematic review; Meta-analysis; Comorbidity; MEDLINE; Internal medicine; Cochrane Library; Oncology; Intensive care medicine","authors":[{"name":"Alfredo Distante","is_ca":false},{"name":"Riccardo Bertolo","is_ca":false},{"name":"Riccardo Campi","is_ca":false},{"name":"Selçuk Erdem","is_ca":false},{"name":"Anna Caliò","is_ca":false},{"name":"Carlotta Palumbo","is_ca":false},{"name":"Nicola Pavan","is_ca":false},{"name":"Chiara Ciccarese","is_ca":false},{"name":"Umberto Carbonara","is_ca":false},{"name":"Michele Marchioni","is_ca":false},{"name":"Eduard Roussel","is_ca":false},{"name":"Zhenjie Wu","is_ca":false},{"name":"Peter F.A. Mulders","is_ca":false},{"name":"Stijn Muselaers","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03505213495838975,"gpt":0.3362367575413587,"spread":0.3011846225829689,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002970164,0.0004735441,0.002868824,0.0001045588,0.00004941802,0.00002545335,0.0001468351,0.0002256075,0.00002291911],"category_scores_gemma":[0.0008131215,0.0002279931,0.001670947,0.0006066574,0.00002615588,0.00002328455,0.00004239197,0.0002995777,0.00000404581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001112017,"about_ca_system_score_gemma":0.001986502,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001996404,"about_ca_topic_score_gemma":0.00001865051,"domain_scores_codex":[0.997847,0.0002009093,0.0009170836,0.0004951958,0.0002880884,0.0002517763],"domain_scores_gemma":[0.9977402,0.00024033,0.0008433203,0.0005159097,0.0005101712,0.0001500534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00003975629,0.00003497158,0.000001320594,0.9548911,0.00126197,0.000002309694,0.00009034105,7.116903e-8,0.000002350871,0.00001610692,0.02228711,0.0213726],"study_design_scores_gemma":[0.0001684022,0.0001755182,3.969032e-7,0.5610767,0.009068524,0.00005447245,0.000003210027,0.000003507506,0.00003489756,0.000008384137,0.4292961,0.0001098576],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001445526,0.9775949,0.0000284971,0.000374888,0.0006937155,0.01842103,0.002726349,0.00002729313,0.0001318521],"genre_scores_gemma":[0.000005046336,0.9791305,0.0002818234,0.0006160424,0.0003033613,0.01690332,0.0005058787,0.00009307198,0.002160938],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.407009,"threshold_uncertainty_score":0.9297287,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2996252896","doi":"10.3233/kca-190075","title":"Utility of FDG-PET/CT in Patients with Advanced Renal Cell Carcinoma with Osseous Metastases: Comparison with CT and <sup>99m</sup> Tc-MDP Bone Scan in a Prospective Clinical Trial","year":2019,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Renal cell carcinoma; Radiology; PET-CT; Clinical trial; Nuclear medicine; Computed tomography; Oncology; Internal medicine","authors":[{"name":"Elizabeth H. Dibble","is_ca":false},{"name":"Sasha Kravets","is_ca":false},{"name":"Su–Chun Cheng","is_ca":false},{"name":"Christopher G. Sakellis","is_ca":false},{"name":"Kathryn P. Gray","is_ca":false},{"name":"Amanda Abbott","is_ca":false},{"name":"Dominick Bossé","is_ca":true},{"name":"Mark M. Pomerantz","is_ca":false},{"name":"Bradley A. McGregor","is_ca":false},{"name":"Lauren C. Harshman","is_ca":false},{"name":"M. Dror Michaelson","is_ca":false},{"name":"Rana R. McKay","is_ca":false},{"name":"Toni K. Choueiri","is_ca":false},{"name":"Katherine M. Krajewski","is_ca":false},{"name":"Heather A. Jacene","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02198469567389538,"gpt":0.3223716724288983,"spread":0.3003869767550029,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005279034,0.0002905198,0.00130438,0.000127392,0.00003881833,0.000007385378,0.00007982866,0.00002212646,0.00008272652],"category_scores_gemma":[0.0002881953,0.0001788213,0.00005172428,0.0003473125,0.0006939435,0.00008465659,0.0000507438,0.0006139185,0.000002401388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008696617,"about_ca_system_score_gemma":0.0007268774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001174925,"about_ca_topic_score_gemma":0.0008021762,"domain_scores_codex":[0.9975882,0.0002322667,0.0006486689,0.0006739068,0.0004601102,0.0003968448],"domain_scores_gemma":[0.9986535,0.0001855347,0.0002819822,0.0003755322,0.0001755135,0.0003279273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05865893,0.001109778,0.9368625,0.0002226339,0.000111146,0.0004072499,0.0006311584,0.00003341289,0.000006949069,0.00000162718,0.0007031041,0.001251455],"study_design_scores_gemma":[0.1351975,0.007095336,0.8543814,0.0008311562,0.0002982551,0.00005972028,0.0006410319,0.0004447682,0.0003220708,0.000006906149,0.0004778436,0.000243967],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958883,0.000766771,0.00001348034,0.0002762133,0.00009063369,0.001915402,0.0001362444,0.000020361,0.0008925919],"genre_scores_gemma":[0.9982976,0.00004305021,0.000882409,0.0003710191,0.00004990037,0.0001251752,0.00004572456,0.00002689611,0.0001582587],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08248109,"threshold_uncertainty_score":0.7292119,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200092447","doi":"10.3233/kca-210117","title":"Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Exelixis; University of Texas Southwestern Medical Center; Burroughs Wellcome Fund","keywords":"Cabozantinib; Medicine; Disease; Renal cell carcinoma; Cancer research; Oncology; Internal medicine; Urology; Pharmacology","authors":[{"name":"Akanksha Sharma","is_ca":false},{"name":"Roy Elias","is_ca":false},{"name":"Alana Christie","is_ca":false},{"name":"Noelle S. Williams","is_ca":false},{"name":"Iván Pedrosa","is_ca":false},{"name":"Georg A. Bjarnason","is_ca":true},{"name":"James Brugarolas","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01581873338030816,"gpt":0.2664854274567906,"spread":0.2506666940764825,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001367077,0.0002899598,0.0004895353,0.000137027,0.00005464002,0.00002689223,0.00007401865,0.00004177627,0.002577856],"category_scores_gemma":[0.0001222527,0.0002252533,0.0001695203,0.0003720657,0.00009317508,0.0000968413,0.00003376465,0.0002226874,0.00004413612],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003592216,"about_ca_system_score_gemma":0.004082616,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001037985,"about_ca_topic_score_gemma":0.0002288335,"domain_scores_codex":[0.9979641,0.000159904,0.0003549183,0.0005554013,0.0005415254,0.0004240946],"domain_scores_gemma":[0.9980158,0.00007310572,0.0001150541,0.0004490957,0.0002298122,0.001117169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01264307,0.003373244,0.8897125,0.001229479,0.000631755,0.04408985,0.0003442877,0.0002345342,0.03324049,0.0003744967,0.01186211,0.002264265],"study_design_scores_gemma":[0.03000542,0.0003428309,0.9389495,0.0004601667,0.0013194,0.0001876611,0.00009634701,0.0005268139,0.02217947,0.0001317914,0.005434654,0.0003659029],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987016,0.005156265,0.00007175124,0.002955175,0.0001428585,0.0006941695,0.0004300451,0.00003491357,0.003498803],"genre_scores_gemma":[0.9908957,0.00007265891,0.0006598184,0.002776481,0.0001530989,0.0003755958,0.0003431472,0.0000458086,0.004677621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04923711,"threshold_uncertainty_score":0.9983339,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3014903654","doi":"10.3233/kca-190076","title":"First-Line Immune Checkpoint Inhibitor-Based Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review","year":2020,"lang":"en","type":"review","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Renal cell carcinoma; Medicine; Oncology; Nivolumab; Cancer research; Internal medicine; Immunotherapy; Cancer","authors":[{"name":"Myuran Thana","is_ca":true},{"name":"Lori Wood","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06481327969497024,"gpt":0.3352854722955182,"spread":0.270472192600548,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006760884,0.001374465,0.009076879,0.0002461613,0.0001277176,0.00004704894,0.0004256538,0.000263916,0.0005419656],"category_scores_gemma":[0.0005913636,0.0008833259,0.003484657,0.0007331476,0.00008063453,0.00005521601,0.00007408667,0.0006179705,0.0001720934],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001699913,"about_ca_system_score_gemma":0.004961084,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001477673,"about_ca_topic_score_gemma":0.000006824075,"domain_scores_codex":[0.9942685,0.0003850195,0.00271964,0.001142944,0.0007895544,0.0006943127],"domain_scores_gemma":[0.9950989,0.0004199589,0.001732713,0.001429488,0.0003423354,0.0009766431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001184058,0.0002974322,7.750463e-7,0.9779803,0.0009190047,0.0002620843,0.00003655994,0.000001023014,0.00001639572,0.000002139158,0.007766272,0.01259967],"study_design_scores_gemma":[0.002855148,0.0008179264,6.116517e-7,0.4936621,0.02184411,0.00007661767,0.000002773269,0.00003342089,0.0004633638,0.000003065575,0.4797603,0.000480615],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002449006,0.972427,0.0001626558,0.002248002,0.0004347406,0.0234914,0.0009369805,0.0001108622,0.0001859607],"genre_scores_gemma":[0.00007938169,0.9717251,0.0009589338,0.003027529,0.0006170775,0.02067683,0.001404469,0.0003298828,0.001180801],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4843181,"threshold_uncertainty_score":0.9999006,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401252649","doi":"10.3233/kca-240005","title":"Real-World Outcomes in Patients with Advanced/Metastatic Renal Cell Carcinoma Receiving Cabozantinib or Other Tyrosine Kinase Inhibitors After Checkpoint Inhibitor-Based Therapy","year":2024,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; University of Calgary","funders":"Ipsen","keywords":"Cabozantinib; Renal cell carcinoma; Medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Oncology; Internal medicine; Cancer research; Cancer; Receptor","authors":[{"name":"Daniel Yick Chin Heng","is_ca":true},{"name":"Gurjyot K. Doshi","is_ca":false},{"name":"Pascale Dutailly","is_ca":false},{"name":"Aude Houchard","is_ca":false},{"name":"Mickael Löthgren","is_ca":false},{"name":"Alisha Monnette","is_ca":false},{"name":"Yunfei Wang","is_ca":false},{"name":"Valérie Perrot","is_ca":false},{"name":"Aly‐Khan A. Lalani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01650825833743548,"gpt":0.2769879987711579,"spread":0.2604797404337224,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001881277,0.0006039942,0.0007597705,0.0005497704,0.00005593777,0.00007376978,0.0001090372,0.00008749072,0.001476556],"category_scores_gemma":[0.00003952498,0.0003723441,0.000209188,0.0008827968,0.0001174514,0.0002131986,0.00003978246,0.0004055592,0.00004839484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009293705,"about_ca_system_score_gemma":0.0012234,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001662859,"about_ca_topic_score_gemma":0.0008666787,"domain_scores_codex":[0.9970167,0.0001014352,0.0006672204,0.0008474827,0.000709844,0.0006573636],"domain_scores_gemma":[0.9985027,0.0001163914,0.0001547959,0.0005798208,0.0001509493,0.0004953207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005817636,0.000909731,0.977617,0.0007071152,0.0001361768,0.0009235591,0.0006371253,0.00006374309,0.004138113,0.000002700808,0.002398359,0.006648747],"study_design_scores_gemma":[0.01459476,0.001829297,0.8464799,0.003040513,0.0002318979,0.000003679548,0.00004714067,0.0001043856,0.1227565,0.000007423117,0.01030665,0.0005978385],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920667,0.002672367,0.00001030639,0.001273683,0.0006065361,0.001608639,0.0002380911,0.0001381306,0.001385528],"genre_scores_gemma":[0.990788,0.000136321,0.001341121,0.001517131,0.0002264734,0.0007616643,0.00008821243,0.0001956622,0.004945403],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1311371,"threshold_uncertainty_score":0.9998729,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3186123873","doi":"10.3233/kca-210116","title":"Bim Expression in Peritumoral Lymphocytes is Associated with Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"Kidney Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Nephrectomy; Medicine; Renal cell carcinoma; Clear cell renal cell carcinoma; Immunohistochemistry; Oncology; Proportional hazards model; Internal medicine; Kidney cancer; Cancer; Metastasis; Clear cell; Pathology; Kidney","authors":[{"name":"Bimal Bhindi","is_ca":false},{"name":"Elizabeth Bearrick","is_ca":false},{"name":"John C. Cheville","is_ca":false},{"name":"Christine M. Lohse","is_ca":false},{"name":"Ross Mason","is_ca":true},{"name":"Paras Shah","is_ca":false},{"name":"Susan M. Harrington","is_ca":false},{"name":"Henan Zhang","is_ca":false},{"name":"Haidong Dong","is_ca":false},{"name":"Stephen A. Boorjian","is_ca":false},{"name":"R. Houston Thompson","is_ca":false},{"name":"Bradley C. Leibovich","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01467300630576564,"gpt":0.2340668076723973,"spread":0.2193938013666316,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000122855,0.0003267475,0.0006125371,0.0001673559,0.00004732022,0.00002850625,0.00008702631,0.00007843861,0.0006490965],"category_scores_gemma":[0.0000493992,0.0002340725,0.00007125313,0.0006185528,0.00006436409,0.0001185103,0.00005858166,0.0002456408,0.00001437411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0013282,"about_ca_system_score_gemma":0.001538201,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001100962,"about_ca_topic_score_gemma":0.0005255798,"domain_scores_codex":[0.997719,0.0001880035,0.0003432512,0.0005767332,0.0006753296,0.0004976506],"domain_scores_gemma":[0.9988403,0.00005532453,0.0001557553,0.0003649092,0.0002115543,0.0003721372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002107908,0.001162012,0.9871246,0.0001732708,0.00004898091,0.001411331,0.0009987247,0.000067252,0.00581668,6.949562e-7,0.000951593,0.0001369261],"study_design_scores_gemma":[0.02026195,0.0009909857,0.7908748,0.0007453487,0.0001677576,0.000006200919,0.000320225,0.0001215274,0.1859712,0.000003389321,0.0002548859,0.0002817457],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964163,0.0008912098,0.000005394983,0.0002461708,0.00009322284,0.0004953212,0.0001351696,0.00002382924,0.001693353],"genre_scores_gemma":[0.9970073,0.00003906541,0.0006451822,0.0006411067,0.00003407997,0.0001027247,0.0002754618,0.0000678382,0.00118726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1962499,"threshold_uncertainty_score":0.9545201,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}